Ivermectin-induced blindness treated with intravenous lipid therapy in a dog

Journal of Veterinary Emergency and Critical Care

Volumn 23, Issue 1, 2013, Pages 58-62

  Epstein, Steven E ^a   Hollingsworth, Steven R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intralipid; Neurotoxin; Toxicology

Indexed keywords

IVERMECTIN; PHOSPHOLIPID; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLINDNESS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; EMULSION; FEMALE;

ANIMALS; BLINDNESS; DOG DISEASES; DOGS; EMULSIONS; FEMALE; IVERMECTIN; PHOSPHOLIPIDS; SOYBEAN OIL;

CANIS FAMILIARIS;

EID: 84873191922     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/vec.12016     Document Type: Article

References (48)

1. Ekesten B. Ophthalmic examination and diagnostics, part 4: electrodiagnostic evaluation of vision, In: Gelatt KN. ed. Veterinary Ophthalmology, 4th ed. Ames, IA: Blackwell; 2007.
2. Ofri R. Retina, In: Maggs DJ, Miller PE, Ofri R. eds. Slatter's Fundamentals of Veterinary Ophthalmology, 4th ed. St. Louis: Elsevier; 2008.
3. Acland GM. Diagnosis and differentiation of retinal diseases in small animals by electroretinography. Semin Vet Med Surg Sm Anim 1988; 3:15-27.
4. Easby SM. Ivermectin in the dog. Vet Rec 1984; 115:45.
5. Paul AJ, Tranquili WJ, Seward RL, et al. Clinical observations in Collies given ivermectin orally. Am J Vet Res 1987; 48:684-686.
6. Houston DM, Parent J, Matushek KJ. Ivermectin toxicosis in a dog. J Am Vet Med Assoc 1987; 191:78-80.
7. Hopkins KD, Marcella KL, Strecker AE. Ivermectin toxicosis in a dog. J Am Vet Med Assoc 1990; 197:93-94.
8. Hadrick MK, Bunch SE, Kornegay JN. Ivermectin toxicosis in two Australian shepherds. J Am Vet Med Assoc 1995; 206:1147-1150.
9. Hopper K, Aldrich J, Haskins SC. Ivermectin toxicity in 17 collies. J Vet Intern Med 2002; 16:89-94.
10. Nelson OL, Carsten E, Bentjen SA, et al. Ivermectin toxicity in an Australian shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies. J Vet Intern Med 2003; 17:354-356.
11. Ketring K. In: Proceedings of presumed ocular toxicity of ivermectin. 13th Annu Kal Kan Symp 1989; 109-110.
12. Wolfer J, Grahn B, Lane S. Diagnostic ophthalmology. Can Vet J 1997; 38:729-730.
13. Kenny PJ, Vernau KM, Puschner B, et al. Retinopathy associated with ivermectin toxicosis in two dogs. J Am Vet Med Assoc 2008; 233:279-284.
14. Plummer CE, Kallberg ME, Ollivier FJ, et al. Suspected ivermectin toxicosis in a miniature mule foal causing blindness. Vet Ophthalmol 2006; 9(1):29-32.
15. Campbell WC, Fisher MH, Stapley EO, et al. Ivermectin: a potent new antiparasitic agent. Science 1983; 221:823-827.
16. Wolstenholme AJ, Rogers AT. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 2005; 131(suppl):S85-S95.
17. 1a on GABA nerves. Prog Clin Biol Res 1982; 97:373-395.
18. 1a modulation of g-aminobutyric acid receptors in rat brain membranes. J Neurochem 1982; 38:375-379.
19. Trailovic SM, Nedeljkovic JT. Central and peripheral neurotoxic effects of ivermectin in rats. J Vet Med Sci 2011; 73(5):591-599.
20. Mealey KL, Bentjen SA, Gay JM, et al. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001; 11:727-733.
21. Mealey KL. Ivermectin: macrolide antiparasitic agents, In: Peterson ME, Talcott PA. eds. Small Animal Toxicology. 2nd ed. St. Louis: Elsevier; 2006.
22. Robin LN, Kalloniatis M. Interrelationship between retinal ischemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA. Doc Ophthalmol 1992; 16:125-130.
23. Yang XL. Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol 2004; 73:127-150.
24. Merola V, Khan S, Gwaltney-Brant S. Ivermectin toxicosis in dogs: a retrospective study. J Am Anim Hosp Assoc 2009; 45:106-111.
25. Marques-Santos LF, Bernardo RR, de Paula EF, et al. Cyclosporin A and trifluoperazine, two resistance modulating agents increase ivermectin neurotoxicity in mice. Pharmacol Toxicol 1999; 84:125-129.
26. Lankas GR, Minsker DH, Robertson RT. Effects of ivermectin on reproduction and neonatal toxicity in rats. Food Chem Toxicol 1989; 27(8):523-529.
27. Sivine F, Plume C, Ansay M. Picrotoxin, the antidote to ivermectin in dogs? Vet Rec 1985; 116:195-196.
28. Gelatt KN. Essentials of Veterinary Ophthalmology, 1st ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000.
29. Clarke DL, Lee JA, Murphy LA, et al. Use of intravenous lipid emulsion to treat ivermectin toxicosis in a border collie. J Am Vet Med Assoc 2011; 239(10):1328-1333.
30. Wright HM, Chen AV, Talcott PA, et al. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1{increment} gene mutation. J Vet Emerg Crit Care 2011; 21:666-672.
31. Mealey KL. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 2004; 27:257-264.
32. Crandell DE, Winberg GL. Moxidectin toxicosis in a puppy successfully treated with intravenous lipids. J Vet Emerg Crit Care 2009; 19:181-186.
33. O'Brien TQ, Clark-Price SC, Evans EE, et al. Infusion of a lipid emulsion to treat lidocaine intoxication in a cat. J Am Vet Med Assoc 2010; 12:1455-1458.
34. Warren J, Thoma R, Georgescu A, et al. Intravenous lipid infusion in the successful resuscitation of local anesthetic-induced cardiovascular collapse after supraclavicular brachial plexus block. Anesth Analg 2009; 108:1578-1580.
35. Sonsino DH, Fischler M. Immediate intravenous lipid infusion in the successful resuscitation of ropivicaine-induced cardiac arrest after infraclavicular brachial plexus block. Reg Anesth Pain Med 2009; 34:276-277.
36. Zhou Y, Zhan C, Li Y, et al. Intravenous lipid emulsions combine extracorporeal blood purification: a novel therapeutic strategy for severe organophosphate poisoning. Med Hypotheses 2010; 74:309-311.
37. Finn S, Uncles D, Willers J, et al. Early treatment of a quetiapine and sertraline overdose with Intralipid. Anaesthesia 2009; 64:191-194.
38. Harvey M, Cave G, Hoggett K. Correlation of plasma and peritoneal dialysate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. Acad Emerg Med 2009; 16(2);151-156.
39. Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008; 51(4):412-415.
40. Weinberg G, Di Gregorio G, Hiller D, et al. Reversal of haloperidol induced cardiac arrest by using lipid emulsion. Ann Intern Med 2009; 150(10):737-738.
41. Dolcourt B, Arron C. Intravenous fat emulsion for refractory verapamil and atenolol induced-shock: a human case report [abstract]. Clin Toxicol 2008; 46:620.
42. Hurley WT, Hanalon P. Lipid emulsion as an antidote at the Washington Poison Control Center; use in carbamazepine, flecaninde, hydrochloroquine, bupivicaine, and buproprion. North American congress of clinical toxicology annual meeting. San Antonio, TX, USA. Clin Toxicol 2009; 47:702-765.
43. Harvey MG, Cave GR. Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. J Med Toxicol 2008; 4(2):71-76.
44. Litz RJ, Roessel T, Heller AR, et al. Reversal of central nervous system and cardiac toxicity after local anesthetic intoxication by lipid emulsion injection. Anesth Anal 2008; 106(5):1575-1577.
45. Fernandez AL, Lee JA, Rahilly L, et al. The use of intravenous lipid emulsion as an antidote in veterinary toxicology. J Vet Crit Care 2011; 21(4):309-320.
46. Kang JH, Yang MP. Effect of a short-term infusion with soybean oil-based lipid emulsion on phagocytic responses of canine peripheral blood polymorphonucreal neutrophilic leukocytes. J Vet Intern Med 2008; 22:1166-1173.
47. Jamaty C, Bailey B, Larocque A, et al. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol 2010; 48:1-27.
48. Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med 2009; 16:815-824.